Cargando…

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia

BACKGROUND: The Brief Assessment of Cognition in Schizophrenia (BACS) is an evaluation of cognitive function that can be completed with more cases. However, there are few studies that compare which factor, disease or aging, is a better determinant of performance on the BACS. The present study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneda, Ayako, Katagai, Takeshi, Yasui-Furukori, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748053/ https://www.ncbi.nlm.nih.gov/pubmed/23983469 http://dx.doi.org/10.2147/NDT.S43280

Ejemplares similares

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
por: Tsuchimine, Shoko, et al.
Publicado: (2013)

Effect of age and disease on bone mass in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2012)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka, Masamichi, et al.
Publicado: (2014)

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects
por: Tsuchimine, Shoko, et al.
Publicado: (2015)

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2021)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey
por: Sugai, Takuro, et al.
Publicado: (2015)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study
por: Yasui-Furukori, Norio, et al.
Publicado: (2014)

Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study
por: Sugawara, Norio, et al.
Publicado: (2022)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
por: Tarakita, Natsumi, et al.
Publicado: (2018)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
por: Yamada, Momoka, et al.
Publicado: (2023)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2021)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
por: Wang, Liang-Jen, et al.
Publicado: (2016)

High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey
por: Sugai, Takuro, et al.
Publicado: (2016)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

Body composition in patients with schizophrenia: Comparison with healthy controls
por: Sugawara, Norio, et al.
Publicado: (2012)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016)

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
por: Ono, Shin, et al.
Publicado: (2018)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita, Tetsu, et al.
Publicado: (2016)

Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
por: Yasui-Furukori, Norio, et al.
Publicado: (2023)

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

Sensitivity and applicability of the Brazilian version of the Brief Assessment of Cognition in Schizophrenia (BACS)
por: Salgado, João Vinícius, et al.
Publicado: (2007)

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014)

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study
por: Hishimoto, Akitoyo, et al.
Publicado: (2022)

PS104. An attempt to construct a 7-item short version of the Temperament and Character Inventory to predict the treatment response of patients with depression
por: Tomito, Tetsu, et al.
Publicado: (2016)

Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
por: Araújo, Geovany Eliberto, et al.
Publicado: (2015)

Factor structure of the University Personality Inventory in Japanese medical students
por: Sugawara, Norio, et al.
Publicado: (2020)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_783i9q83gi4fog7i4ja7f4vm1q